secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-10-28T23:59:59+00:00
Accession:  0001213900-25-103068
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio to host Q3 2025 results conference call on October 30, 2025
----------------------------------------------------------------------

- Company will report Q3 2025 financial results and provide corporate update on October 30, 2025 at 4:30 PM ET.
- Dial-in details: 1-800-225-9448 (US), 1-203-518-9708 (international), Conference ID: INMUNE.
- Webcast accessible via provided link; replay available through Nov 13 by dialing 1-844-512-2921 (PIN 11159914).
- No financial results disclosed in this press release; results will be provided during the call.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025103068/0001213900-25-103068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025103068/ea0262255-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-103068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer